News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BeiGene Co.,Ltd Signs Up Industry Veterans for Scientific Advisory Board


8/21/2013 8:59:44 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

August 20, 2103 -- BeiGene, Ltd., a Beijing pharma formed in 2010, announced a Scientific Advisory Board that includes an international list of experts with experience in oncology drugs. The Board is comprised of: Neal Rosen, MD, PhD; David Schenkein, MD; Charles Sawyers, MD; Xiaodong Wang, PhD; and Steve Young, PhD. BeiGene discovers its own cancer drug candidates and in-licenses molecules that are close to clinical stage for China development. It calls itself a proof-of-concept company. More details....

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES